These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sera from neuromyelitis optica patients disrupt the blood-brain barrier. Shimizu F; Sano Y; Takahashi T; Haruki H; Saito K; Koga M; Kanda T J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):288-97. PubMed ID: 22100760 [TBL] [Abstract][Full Text] [Related]
4. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane. Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518 [TBL] [Abstract][Full Text] [Related]
5. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545 [TBL] [Abstract][Full Text] [Related]
6. Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica. Tasaki A; Shimizu F; Sano Y; Fujisawa M; Takahashi T; Haruki H; Abe M; Koga M; Kanda T J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):419-30. PubMed ID: 24259591 [TBL] [Abstract][Full Text] [Related]
7. GRP 78 antibodies are associated with clinical phenotype in neuromyelitis optica. Shimizu F; Takeshita Y; Hamamoto Y; Nishihara H; Sano Y; Honda M; Sato R; Maeda T; Takahashi T; Fujikawa S; Kanda T Ann Clin Transl Neurol; 2019 Oct; 6(10):2079-2087. PubMed ID: 31568704 [TBL] [Abstract][Full Text] [Related]
8. Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema. Ratelade J; Bennett JL; Verkman AS PLoS One; 2011; 6(11):e27412. PubMed ID: 22076159 [TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid. Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196 [TBL] [Abstract][Full Text] [Related]
11. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica. Cayrol R; Saikali P; Vincent T Ann N Y Acad Sci; 2009 Sep; 1173():478-86. PubMed ID: 19758189 [TBL] [Abstract][Full Text] [Related]
12. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Nicchia GP; Mastrototaro M; Rossi A; Pisani F; Tortorella C; Ruggieri M; Lia A; Trojano M; Frigeri A; Svelto M Glia; 2009 Oct; 57(13):1363-73. PubMed ID: 19229993 [TBL] [Abstract][Full Text] [Related]
13. Evidence against cellular internalization in vivo of NMO-IgG, aquaporin-4, and excitatory amino acid transporter 2 in neuromyelitis optica. Ratelade J; Bennett JL; Verkman AS J Biol Chem; 2011 Dec; 286(52):45156-64. PubMed ID: 22069320 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase. Tradtrantip L; Asavapanumas N; Verkman AS Mol Pharmacol; 2013 Jun; 83(6):1268-75. PubMed ID: 23571414 [TBL] [Abstract][Full Text] [Related]
15. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link. Jarius S; Wildemann B Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872 [TBL] [Abstract][Full Text] [Related]